1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/57778
Registro completo de metadatos
Campo DCValorIdioma
dc.creatorEduardo Paulinopt_BR
dc.creatorAngélica Nogueira Rodriguespt_BR
dc.creatorAknar F. C. Calabrichpt_BR
dc.creatorAndrea P. G. Guimarãespt_BR
dc.creatorAndreia C. Melopt_BR
dc.creatorDaniela Freitaspt_BR
dc.creatorFernando C. Malufpt_BR
dc.creatorLilian D. Faronipt_BR
dc.creatorMarcelo A. Vieirapt_BR
dc.creatorReitan Ribeiropt_BR
dc.date.accessioned2023-08-11T21:49:37Z-
dc.date.available2023-08-11T21:49:37Z-
dc.date.issued2018-12-26-
dc.citation.spage1pt_BR
dc.citation.epage5pt_BR
dc.identifier.doi10.5935/1806-6054.20190008pt_BR
dc.identifier.issn18066054pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57778-
dc.description.resumoGynecologic cancers constitute an important burden of disease around the world. Estimates from GLOBOCAN 2018 reveals approximately 1,247,300 incident casesand 596,000 related deaths of cancers of the uterine cervix, corpus uteri, and ovarian, annually around the world. In 2018 lots of promising results to improve disease control have been presented at international gynecological cancer meetings. The current review highlights some of the top gynecologic cancer news of 2018, including the new standard of care for BRCAmutant ovarian cancer patients with maintenance olaparib in first line, benefit of bevacizumab rechallenge for relapsed ovarian cancer patients, and the unexpected results of worse overall survival with minimally invasive surgery in early cervical cancer, among others.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofBrazilian Journal Of Oncology-
dc.rightsAcesso Abertopt_BR
dc.subjectBevacizumabpt_BR
dc.subjectWomen's Healthpt_BR
dc.subjectGenital Neoplasms, Femalept_BR
dc.subject.otherBevacizumabpt_BR
dc.subject.otherSaúde da mulherpt_BR
dc.subject.otherNeoplasias dos Genitais Femininospt_BR
dc.title2018 in review: gynecologic cancer insightspt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttp://www.brazilianjournalofoncology.com.br/details/55/en-US/2018-in-review--gynecologic-cancer-insightspt_BR
Aparece en las colecciones:Artigo de Periódico

archivos asociados a este elemento:
archivo Descripción TamañoFormato 
2018 in review gynecologic cancer insights pdfa.pdf105.11 kBAdobe PDFVisualizar/Abrir
Mostrar registro simple del elemento Visualizar estadísticas


Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.